The salivary alpha-amylase concentration in patients with rheumatoid arthritis: A case-control study

• Published in: Dental research journal 2023, Vol.20 (1), p.43-43
• Main Authors: Pakravan, Fahimeh, Isfahani, Mehdi Nasr, Ghorbani, Mateen, Salesi, Naghmeh, Salesi, Mansour
• Format: Article
• Language: English
• Subjects: Original; rheumatoid arthritis; salivary alpha-amylases; stress disorder
• ISSN: 1735-3327; 2008-0255
• DOI: 10.4103/1735-3327.372660

Rheumatoid arthritis (RA) is one of the most common chronic inflammatory diseases. Previous studies have reported an association between stress and salivary alpha-amylase. The aim of this study was to investigate the concentration of salivary alpha-amylase in patients with RA (by elimination of stress factor). In this case-control study, we enrolled 50 patients with RA and 48 healthy patients as the control group. The perceived stress scale questionnaire was used to evaluate scores of stress in both case and control groups, and then the participants with high scores of stress were excluded from the study. Moreover, the alpha-amylase activity kit was used for the assessment of the levels of salivary alpha-amylase. In all analyses, the significance level was considered to be < 0.05. Finally, the obtained data were analyzed by SPSS22. Our results indicated a high score of stress in the case group (19.42 ± 5.83 units) compared with the control group (18.02 ± 6.07 units) which was not statistically significant ( < 0.248). Moreover, we demonstrated a high salivary alpha-amylase concentration in the case group (340.65 ± 38.04 units) compared to the control group (302.62 ± 58.72 units), which was statistically significant ( < 0.001). The sensitivity and specificity of this method, at >312 alpha-amylase concentrations, were 80% and 46%, respectively. In general, we indicated that the alpha-amylase concentration in patients with RA is higher than the healthy controls, and can be used as a codiagnostic factor.